About Us
The Treatment
Adult stem cells, known as mesenchymal stem cells (MSCs), have the unique ability of highly efficient differentiating into bone cells (osteoblasts) and cartilage cells (chondrocytes). As MSCs may be readily obtained and culture-expanded in number, direct introduction of MSCs into a diseased/injured area of a bird should be considered a potential treatment.
Our Mission
We believe in creating innovative technology with integrity and purpose to make a change in the diseases that affect the avian species. AviCell is our first step in achieving this mission.
Our Future
Bickford Pharma is in the beginning stages of growth and development. Through pioneering new and evolving technology, we plan to create a solution to common injuries affecting birds with bone marrow-derived avian stem cells.
Meet the Team
Erek Bickford - Owner and President
Erek is a recent graduate of the University of Rhode Island with degrees in Neuropharmacology and Spanish, but from a small town in New Hampshire where Bickford Pharma is based. The product itself, AviCell, was acquired from Recellerate to expand and seek FDA approval.